☆Enavate Sciences GP, LLC
Quality Q
0.851
AUM ($M)
345
Positions
7
Turnover
0.10
Top-10 wt
100%
Herfindahl
0.240
History (qtrs)
6
Excess Return
—
AI Eval Run AI Eval
Holdings · 7 positions · portfolio value $345M
| Ticker | Name | Activity | Security Type | Weight | Δ Weight | Value ($M) | Shares | Δ Shares | Qtrs Held | Excess Return |
|---|---|---|---|---|---|---|---|---|---|---|
| ☆SION funds › | SIONNA THERAPEUTICS INC | HOLD | — | 31.6% | +3.3% | 109.0 | 2,478,030 | +0 | 5 | — |
| ☆ZBIO funds › | ZENAS BIOPHARMA INC | HOLD | — | 28.8% | +7.0% | 99.5 | 3,919,159 | +0 | 5 | — |
| ☆IMNM funds › | IMMUNOME INC | HOLD | — | 22.2% | -0.3% | 76.6 | 3,613,799 | +0 | 5 | — |
| ☆BBOT funds › | BRIDGEBIO ONCOLOGY THERAPEUT | HOLD | — | 5.8% | -0.9% | 20.0 | 2,626,946 | +0 | 4 | — |
| ☆CMPX funds › | COMPASS THERAPEUTICS INC | HOLD | — | 4.9% | -6.8% | 17.1 | 7,788,150 | +0 | 5 | — |
| ☆UPB funds › | UPSTREAM BIO INC | HOLD | — | 4.9% | -1.4% | 17.0 | 2,459,703 | +0 | 5 | — |
| ☆CAMP funds › | CAMP4 THERAPEUTICS CORP | TRIM | — | 1.8% | -0.9% | 6.2 | 1,425,541 | -765,379 | 5 | — |
Point-in-time history
| Period | AUM ($M) | Positions | Turnover | Top-10 wt | Herfindahl | Quality Q | Skill | Universe |
|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 345 | 7 | 0.10 | 100% | 0.240 | 0.851 | — | in |
| 2026Q1 | 352 | 7 | 0.14 | 100% | 0.201 | 0.813 | — | in |
| 2025Q4 | 507 | 7 | 0.06 | 100% | 0.190 | 0.900 | — | in |
| 2025Q3 | 328 | 7 | 0.14 | 100% | 0.180 | 0.770 | — | in |
| 2025Q2 | 177 | 6 | 0.10 | 100% | 0.203 | 0.793 | — | entered |
| 2025Q1 | 133 | 6 | 0.00 | 100% | 0.185 | 0.000 | — | out |
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short.
JSON: /api/signals ·
/api/funds ·
/api/status